PCSA
Processa Pharmaceuticals
$1.89
+$0.04 (+2.16%)Oct 29, 2026
Key metrics
The numbers that frame PCSA today
- Market cap
- $5.28M
- ROIC
- 54,679.2%
- Div yield
- 0%
- 52wk Low
- $1.04
- 52wk High
- $10.84
Growth
Revenue and earnings trend for PCSA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCSA
Is Processa Pharmaceuticals a good buy?
No. Processa Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Processa Pharmaceuticals is selling at a very high price.
What is the market capitalization of PCSA?
Processa Pharmaceuticals's market capitalization is $5.28M.
What is the 52-week high for PCSA stock?
The 52-week high for Processa Pharmaceuticals is $10.84. The current close of $1.89 is 82.6% below that high.
What is the 52-week low for PCSA stock?
The 52-week low for Processa Pharmaceuticals is $1.04. The current close of $1.89 is 81.6% above that low.
Does PCSA stock pay dividends?
Processa Pharmaceuticals does not currently show a dividend per share in the company data.